Showing results (81-90 of 93) with videos related to
Sort By:
Pageof 10
Nature Communications|November 10, 2020
Human endogenous retroviruses form a reservoir of T cell targets in hematological cancersSunil Kumar Saini, Andreas Due Ørskov, Anne-Mette Bjerregaard, et al.Cancer Research|June 29, 2017
Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ SignalingMarco Donia, Katja Harbst, Marit van Buuren, et al.Nature Communications|April 12, 2022
Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinomaJeppe Sejerø Holm, Samuel A Funt, Annie Borch, et al.Frontiers in Immunology|March 31, 2023
First in man study: Bcl-Xl_42-CAF®09b vaccines in patients with locally advanced prostate cancerSofie Kirial Mørk, Per Kongsted, Marie Christine Wulff Westergaard, et al.Nature Communications|February 5, 2026
An mRNA-delivered consensus allergen induces a neutralizing IgG response against food and pollen allergensMark Møiniche, Kristoffer H Johansen, Jorge Parrón-Ballesteros, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2022
Safety, Outcomes, and T-Cell Characteristics in Patients with Relapsed or Refractory MDS or CMML Treated with Atezolizumab in Combination with GuadecitabineCasey L O'Connell, Maria R Baer, Andreas Due Ørskov, et al.Journal for Immunotherapy of Cancer|May 23, 2024
Dose escalation study of a personalized peptide-based neoantigen vaccine (EVX-01) in patients with metastatic melanomaSofie Kirial Mørk, Signe Koggersbøl Skadborg, Benedetta Albieri, et al.Oncoimmunology|July 4, 2012
TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patientsPia Kvistborg, Chengyi Jenny Shu, Bianca Heemskerk, et al.Frontiers in Immunology|April 18, 2024
IMPROVE: a feature model to predict neoepitope immunogenicity through broad-scale validation of T-cell recognitionAnnie Borch, Ibel Carri, Birkir Reynisson, et al.Journal for Immunotherapy of Cancer|August 16, 2023
TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapySiri Amanda Tvingsholm, Marcus Svensson Frej, Vibeke Mindahl Rafa, et al.Pageof 10